Michael A. Mussallem, Chairman & CEO at Edwards Lifesciences Corp (EW), sold 134,955 shares at $77.86 ($2.3M) on 2023-03-14, disclosed to the SEC on 2023-03-14.
Seasonal sale ($2.3M) by Chairman & CEO — this insider has traded EW in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 96,405 | $0 | 0.0% |
| 2 | $0.00 | 9,500 | $0 | 0.0% |
| 3 | $77.32 | 9,175 | $709K | 31.5% |
| 4 | $77.32 | 9,175 | $709K | 31.5% |
| 5 | $77.86 | 10,700 | $833K | 37.0% |
| Total | $16.69 avg | 134,955 |
| $2.3M |
| 100% |
| Filing → |
| EW | SELL | 2024-03-04 | $3.7M | — | Filing → |
| EW | SELL | 2024-02-05 | $5.0M | — | Filing → |
| EW | SELL | 2024-01-05 | $2.3M | — | Filing → |